Dr. Mads Daugaard

Dr. Mads Daugaard

B.Sc. Biology, University of Copenhagen, Denmark 
M.Sc. Molecular Biology and Biochemistry, University of Copenhagen
Ph.D. Molecular Cancer Biology and Pathology, University of Copenhagen

Team: 
Clinical and Research Scientists
Positions: 

Senior Research Scientist, Vancouver Prostate Centre
Head, Molecular Pathology & Cell Imaging Core Facility, Vancouver Prostate Centre
Assistant Professor, Department of Urologic Sciences, University of British Columbia

 

Dr. Mads Daugaard is a molecular biologist specialized in tumour-associated stress signaling pathways and tumour targeting systems. He earned his PhD degree from the Faculty of Health Sciences, University of Copenhagen, for his studies on heat shock proteins in relation to cancer cell survival mechanisms. After getting his PhD, Dr. Daugaard received a junior fellowship award to continue his work at the Danish Cancer Society Research Centre on stress signaling pathways related to DNA damage response mechanisms. In 2010, Dr. Daugaard received a research award from the Danish Cancer Society Scientific Committee to do postdoctoral training in molecular pathology at the BC Cancer Research Centre and the Department of Pathology and Laboratory Medicine, University of British Columbia.

Dr. Daugaard’s ongoing research focuses on molecular and biochemical events underlying alternative polyadenylation of mRNAs, chromatin context-dependent DNA repair, and development of resistance to chemotherapy. Another aspect of Dr. Daugaard’s research relates to discovery and development of novel tumour targeting systems based on parasite-derived recombinant proteins relevant for therapeutic and diagnostic applications in cancer.

Dr. Daugaard has published original research in top-tier scientific journals and received competitive international funding support from institutions such as the US Department of Defense, Stand Up 2 Cancer, the Danish Cancer Society, and the Novo Nordisk Foundation. In the 2014 competition, Dr. Daugaard received the Prostate Cancer Canada and Safeway Rising Star Award. Dr. Daugaard has been a board member of the European Workshop on Cell Death scientific committee since 2010.

Dr. Daugaard is co-founder of the Danish biotechnology company VAR2 Pharmaceuticals ApS, where he serves as Chief Scientific Officer (CSO), and Chairman of the board of directors (COB).

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Father's Day Walk/Run for Prostate Cancer: June 18

The Raymond James Father's Day Wak Run for Prostate Cancer, raising funds for Prostate Cancer Foundation BC, takes place Sunday June 18.  Our Centre has a team registered at the Metro Vancouver site; click here to join or donate.

 

Employment

Work at the Vancouver Prostate Centre

Monday, January 30, 2017

Dr. Amina Zoubeidi leads identification of gene linked to growth of aggressive neuroendocrine prostate cancer (NEPC)

DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.